Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP)
Rebecca Ziemann
Ketamine-Assisted Psychotherapy (KAP) is a new therapeutic modality in which ketamine is used as an adjunct to psychotherapy to help eligible patients experience sustained improvement in symptoms and clinical outcomes. During KAP, eligible patients self-administer sublingual ketamine in the context of a psychotherapy session with a qualified licensed mental health professional. Like any new modality, questions arise about scope of practice from all the stakeholders involved, including mental health professionals, insurance providers & patients alike. Join industry leaders Fluence, Journey Clinical, and Bruce Hillow, Esq for a roundtable discussion about how to navigate this timely and important topic. This is a free, invite-only webinar for members of the Journey Clinical and Fluence communities.
Learning Objectives
At the end of this course, the participant will be able to:
Define Ketamine-Assisted Psychotherapy
Clarify the role of each stakeholder within the context of KAP (prescriber, patient, psychotherapist)
Discuss scope of practice for licensed mental health professionals in the context of KAP.
Skills / Knowledge
- Scope of Practice
- Clinical Assessment
- Ketamine Administration